In an international study led by UCLA, researchers have shown that giredestrant, a next-generation oral selective estrogen ...

The investigational, oral selective estrogen receptor degrader (SERD) giredestrant given as an adjuvant therapy showed significant improvement in invasive disease-free survival (iDFS) compared with ...

Wistar Institute scientist Maureen Murphy wants to solve a decades-long mystery: Why is ovarian cancer often resistant to hormone therapy? In a recently published study, she shared a new theory as to ...

Enclomiphene is a non-steroidal selective estrogen receptor modulator (SERM) sometimes used to treat male secondary hypogonadism, or low testosterone caused by problems with the hypothalamus or ...

Jaimie Veale was the founding President of the Professional Association for Transgender Health Aotearoa (PATHA). She is supported by a Rutherford Discovery Fellowship, awarded by Royal Society Te ...

Plasma Treatment Shows Promise For Menopause Symptoms Among Breast Cancer Survivors By Dennis Thompson HealthDay ReporterTHURSDAY, Nov. 20, 2025 (HealthDay News) — Plasma infusions may help breast ...

When performing onstage, Dania Hallak, a singer and songwriter, sometimes found she couldn’t hit lower notes. Her vocal coach suggested it was performance anxiety. Hallak saw her doctor, who ...

Please provide your email address to receive an email when new articles are posted on . Initiating estrogen therapy a decade before menopause lowered the risk for breast cancer, stroke and CVD.

For 40 years, it has been the standard in post-heart attack health care, but a new study from the European Society of Cardiology is putting the usage of beta blockers in limbo. While the new study may ...